Form 4 for AGL agilon health, inc.
Accepted 2021-09-15 00:00:00 ET · period of report 2021-09-14 · accession 0001209191-21-056200 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-09-15 | 2021-09-14 | AGL | Desai Veeral | Chief Strategy, Dev. Off | M - OptEx | $1.00 | +121.0K | 383.0K | +46% | +$121.0K |
| D | 2021-09-15 | 2021-09-14 | AGL | Desai Veeral | Chief Strategy, Dev. Off | S - Sale+OE | $28.98 | -121.0K | 262.0K | -32% | -$3.51M |
| D | 2021-09-15 | 2021-09-14 | AGL | Desai Veeral | Chief Strategy, Dev. Off | M - OptEx | $0.00 | -121.0K | 1.08M | -10% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-09-14 | M | A | 121,001 | $1.00 | 382,957 | D | — | — | (F1) Includes restricted stock units. |
| 2 | Common | Common Stock | 2021-09-14 | S | D | 121,001 | $28.98 | 261,956 | D | — | — | (F1) Includes restricted stock units. |
| 3 | Derivative | Options (Rights to Buy) | 2021-09-14 | M | D | 121,001 | $0.00 | 1,078,999 | D | $1.00 · — to 2027-04-27 | 121,001 Common Stock | (F2) These options were granted on April 27, 2017, and fully vested on April 24, 2021. |